Ciprofloxacin 0 — Class II drug recall D-0626-2025
Ongoing recall by Sandoz Inc, reported 2025-09-17, distributed in CA. Temperature Abuse
| Recall number | D-0626-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sandoz Inc, Princeton, NJ, United States |
| Recall initiated | 2025-08-13 |
| Classified | 2025-09-10 |
| Reported by FDA | 2025-09-17 |
| Distributed | CA |
| Quantity | 1,680 bottles |
| Reason classes | temperature control |
| NDC | 00781-6186, 00781-6186-67 |
| Lot numbers | VNF35A |
| Expiration dates | 2026-08-31 |
Product
Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67
Reason for recall
Temperature Abuse
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0626-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.